Fluticasone furoate 50mcg, 100mcg, 200mcg; per inhalation; dry pwd for oral inhalation. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for ...
A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...
GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved fluticasone furoate inhalation powder as a once-daily corticosteroid for maintenance ...
New Inhalers for Asthma, COPD Launched by GSK GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation ...
The US Food and Drug Administration (FDA) has approved fluticasone furoate inhalation powder (Arnuity Ellipta, GlaxoSmithKline) as maintenance treatment for asthma in patients aged 12 years and older, ...
GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ARNUITY ELLIPTA contains the active ingredient fluticasone furoate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results